Skip to main content
Premium Trial:

Request an Annual Quote

$5.5 Million in Tobacco Cash Funds Bioinformatics Consortium for Cancer Research

NEW YORK, July 3-A group of six Pennsylvania cancer institutes will launch a bioinformatics consortium for cancer research with $5.5 million from the state tobacco settlement fund, the University of Pittsburgh Cancer Institute said yesterday.

 

The project will build a database of clinical trial information, set up a biorepository of serum and tissue samples, and coordinate the bioinformatics data from all six member institutions.

 

The member institutes have formed a consortium called the Pennsylvania Cancer Alliance. It includes the UPCI, Fox Chase Cancer Center, Thomas Jefferson University's Kimmel Cancer Center, the University of Pennsylvania's Abramson Cancer Center, Penn State Cancer Institute and the Wistar Institute.

 

Members will also collaborate with biotech companies and other Pennsylvania researchers.

 

Aims include identifying new biomarkers for cancer, improving cancer type classification and allowing for more accurate disease prognosis.

 

The Pennsylvania Department of Health will fund the consortium through funds established by a settlement between the state and tobacco companies.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.